about
Hepatitis C: a review for primary care physiciansManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingPhenotypic Characterization of Resistant Val36 Variants of Hepatitis C Virus NS3-4A Serine ProteaseOptimization of linear double-stranded RNA for the production of multiple siRNAs targeting hepatitis C virusFinding candidate drugs for hepatitis C based on chemical-chemical and chemical-protein interactionsModulation of CD4⁺ T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis.Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatmentInterferons and interferon regulatory factors in malariaDevelopment of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity.Providing treatment for hepatitis C in an Australian district centre.Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.Molecular and contextual markers of hepatitis C virus and drug abuse.Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.The importance of blood-borne viruses in elevated cancer risk among opioid-dependent people: a population-based cohort study.Inhibitors for the hepatitis C virus RNA polymerase explored by SAR with advanced machine learning methods.Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverageCell-Penetrating Peptides for Antiviral Drug Development.Screening in liver disease.Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patients.Modulation of the anti-inflammatory interleukin 10 and of proapoptotic IL-18 in patients with chronic hepatitis C treated with interferon alpha and ribavirin.Hepatitis C (chronic)
P2860
Q22306040-ED4A6547-1C00-4E85-B8D5-3419B45E6279Q27477626-07FFDB82-127D-4DD9-B6E3-73746557A8EBQ27485288-5BB936B7-B80A-4D50-ACEB-80A79CCB8D0BQ27488340-8F7CEDC1-0704-47F1-AEFF-C499DC39A6DCQ28543010-170174FF-DA90-4356-B943-29487D8A7B14Q33395512-FD178F54-3307-4AF5-A3AC-557B164445ABQ33557770-119F85CA-6BF7-48C3-A026-DBB1EA760B98Q34012443-F9836854-4C03-4390-9101-FF9319247EB5Q35182301-633A1E58-8093-4D59-B0D1-104CBC880456Q35518843-32023C39-0A33-4BFC-80DD-42A1183703A6Q35595630-630B8D76-106C-4C65-906A-0C36D52B70EDQ35660841-7C0D3D32-0AB2-47F6-AB50-4EE4EB11974AQ36272393-4282C58A-D45B-4A05-AC57-4B6E0CE43BCEQ36370353-FA349BE7-6C4C-4157-A758-34A7C5E245DBQ36841780-7B6FC130-38A3-4B84-A6C1-9AE35486BC87Q37134476-00E408E2-FDE1-431C-87A4-7F60977F3C5FQ38974187-D2ED0417-F486-4040-BC7F-CEA6CACC0643Q42726447-363798FB-5E96-4F4B-AA09-B2ECF466DEEEQ42998257-0F91F817-0578-47F2-8BA6-D06FA5BDC16BQ42999417-3EE9B4B8-BC8A-4544-A93E-705386766D1CQ56932766-F6CC6D42-7A25-4773-9CBA-7AE748820333
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of chronic hepatitis C: a systematic review.
@ast
Treatment of chronic hepatitis C: a systematic review.
@en
Treatment of chronic hepatitis C: a systematic review.
@nl
type
label
Treatment of chronic hepatitis C: a systematic review.
@ast
Treatment of chronic hepatitis C: a systematic review.
@en
Treatment of chronic hepatitis C: a systematic review.
@nl
prefLabel
Treatment of chronic hepatitis C: a systematic review.
@ast
Treatment of chronic hepatitis C: a systematic review.
@en
Treatment of chronic hepatitis C: a systematic review.
@nl
P2093
P2860
P356
P1433
P1476
Treatment of chronic hepatitis C: a systematic review.
@en
P2093
Eric B Bass
Geetanjali Chander
H Franklin Herlong
Kelly A Gebo
Mark S Sulkowski
Michael S Torbenson
Mollie W Jenckes
P2860
P304
P356
10.1053/JHEP.2002.37146
P407
P433
P577
2002-11-01T00:00:00Z